Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01034709 · ClinicalTrials.gov registry record
Evaluation of the Artus® CMV PCR Test
A clinical trial of Cytomegalovirus Infections, sponsored by QIAGEN Gaithersburg.
- Completed
- Registry status
- 111
- Enrollment target
- 5
- Study locations
NCT01034709: Completed study of Cytomegalovirus Infections, sponsored by QIAGEN Gaithersburg.
NCT01034709 is a study of Cytomegalovirus Infections that has completed, run by QIAGEN Gaithersburg. The registered enrollment target is 111 participants, below the 198-participant average among 24 other Cytomegalovirus Infections trials with a reported enrollment target (44% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01034709, a study of Cytomegalovirus Infections, has completed, sponsored by QIAGEN Gaithersburg.
- COMPLETED
- Registry status
- 111 participants
- Enrollment target
- 5
- Study locations
Study Summary
Subjects with symptomatic CMV infection, who are enrolled in this clinical study, will be monitored during antiviral therapy.
Primary Outcome
The CMV viral load was measured by both the artus CMV RG PCR test and the COBAS® AmpliPrep/COBAS® TaqMan® CMV Test at the investigational sites and then the percent agreement between the two tests was determined.
Conditions Studied
Study Locations (5)
Florida
- University of Miami - Miami
- LifeLink Health Care Institute - Tampa
California
- University of California - Los Angeles - Los Angeles
Georgia
- Emory University Hospital - Atlanta
Indiana
- Indiana University - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2009-12 |
| Est. Completion | 2014-06 |
What the finished NCT01034709 record still lists
NCT01034709 is an observational study that tracks outcomes without assigning an intervention. The registered 111 participants enrollment target is mid-sized for trials with a published cap, below the 198-participant average among 24 other Cytomegalovirus Infections trials with a reported enrollment target (44% lower).
The record links to 1 condition, with Cytomegalovirus Infections appearing as the primary indexed condition, and to 0 interventions.
NCT01034709 lists 5 locations in 4 states (Florida, California, Georgia).
Frequently Asked Questions
What is clinical trial NCT01034709 about?
NCT01034709 is a clinical study titled "Evaluation of the Artus® CMV PCR Test". Subjects with symptomatic CMV infection, who are enrolled in this clinical study, will be monitored during antiviral therapy.
What is the current status of trial NCT01034709?
This trial is currently completed. The enrollment target is 111 participants. The study started on 2009-12. Estimated completion is 2014-06.
What conditions does trial NCT01034709 study?
This clinical trial studies the following conditions: Cytomegalovirus Infections.
Who is sponsoring clinical trial NCT01034709?
This trial is sponsored by QIAGEN Gaithersburg, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01034709 being conducted?
This trial has 5 study locations across California, Florida, Georgia, Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cytomegalovirus Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01034709's enrollment target sits among peer trials
111 8th of 24 higher than 17 of 24 other Cytomegalovirus Infections trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cytomegalovirus Infections trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients
RECRUITING · Phase 4
-
Open Label Trial of Oral Letermovir for CMV Prophylaxis in Thoracic Transplant Recipients
RECRUITING · Phase 2
-
Cytomegalovirus (CMV) Transmission and Immune Tracking (TransmIT) Study
RECRUITING
-
R-MVST Cells for Treatment of Viral Infections
RECRUITING · Phase 1
-
Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With Compromised Immunity
RECRUITING · Phase 1
-
Virus Specific Cytotoxic T-Lymphocytes (CTLs) for Refractory Cytomegalovirus (CMV)
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03875716 · 111 participants · NA
Study of De_Intensified Postoperative Radiation Therapy for HPV Associated Oropharyngeal Squamous Cell Carcinoma
- NCT04693468 · 111 participants · Phase 1
Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial
- NCT05263050 · 111 participants · Phase 2
Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
- NCT05600842 · 111 participants
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia